Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ETON PHARMACEUTICALS, INC.

(ETON)
  Report
Delayed Nasdaq  -  03:59 2022-09-23 pm EDT
2.070 USD   -4.61%
09/19ETON PHARMACEUTICALS, INC.(NASDAQGM : ETON) dropped from S&P Global BMI Index
CI
09/13Eton Pharmaceuticals Adds FDA-Approved Rare Disease Product to Metabolic Genetics Portfolio
MT
09/13ETON PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Sinking in Monday Trading

07/18/2022 | 01:29pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ETON PHARMACEUTICALS, INC. -4.61% 2.07 Delayed Quote.-51.75%
NABRIVA THERAPEUTICS PLC -6.61% 2.26 Delayed Quote.-84.91%
NASDAQ COMPOSITE -1.80% 10867.93 Real-time Quote.-30.53%
SHANGHAI A INDEX -0.66% 3236.52 Real-time Quote.-15.15%
SHANGHAI STOCK EXCHANGE B SHARES INDEX -3.04% 299.0373 Real-time Quote.4.61%
ZAI LAB LIMITED -0.88% 37 Delayed Quote.-41.13%
All news about ETON PHARMACEUTICALS, INC.
09/19ETON PHARMACEUTICALS, INC.(NASDAQGM : ETON) dropped from S&P Global BMI Index
CI
09/13Eton Pharmaceuticals Adds FDA-Approved Rare Disease Product to Metabolic Genetics Portf..
MT
09/13ETON PHARMACEUTICALS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/13Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betain..
GL
09/13Eton Pharmaceuticals Announces Acquisition of FDA-Approved Rare Disease Product, Betain..
AQ
08/30Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Co..
GL
08/30Eton Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Co..
AQ
08/15ETON PHARMACEUTICALS : Material Event - Form 8-K
PU
08/15ETON PHARMACEUTICALS, INC. : Other Events (form 8-K)
AQ
08/11ETON PHARMACEUTICALS : Reports Second Quarter 2022 Financial Results - Form 8-K
PU
More news
Analyst Recommendations on ETON PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2022 21,1 M - -
Net income 2022 -11,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -4,70x
Yield 2022 -
Capitalization 52,4 M 52,4 M -
Capi. / Sales 2022 2,48x
Capi. / Sales 2023 1,41x
Nbr of Employees 17
Free-Float 82,5%
Chart ETON PHARMACEUTICALS, INC.
Duration : Period :
Eton Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ETON PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 2,07 $
Average target price 9,00 $
Spread / Average Target 335%
EPS Revisions
Managers and Directors
Sean E. Brynjelsen President, Chief Executive Officer & Director
James Gruber Chief Financial Officer
Norbert G. Riedel Chairman
Charles J. Casamento Independent Director
Paul Victor Maier Independent Director
Sector and Competitors